|
Biological Activity:
Dopamine D2 and D3 receptor antagonist (Ki 2.8 and 3.2 nM for D2 and D3 respectively); Claimed to be atypical antipsychotic with low incidence of EPS.
References: online 1, 2
H Loo et al. Amisulpride versus placebo in the medium-term treatment of the negative symptoms of schizophrenia. Br. J. Psychiatry 1999, 170, 18-22.
H Choemaker et al. Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity. J. Pharmacol. Exp. Ther. 1997, 280/1, 83-97.
Chemical Name:4-amino-N-[(1-ethylpyrrolidin-2-yl)methyl]-5-ethylsulfonyl-2-methoxy-benzamide
|